SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
22-Jun-21 5:21 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Conversion Duplicate | 443,265 | -- | -- | 100% 0 to 443.26K | |
22-Jun-21 5:21 PM View: | Verve Therapeutics, Inc. (VERV) | 21-Jun-21 | Private Purchase | 370,000 | $19.00 | $7,030,000.00 | 83% 443.26K to 813.26K | |
06-Nov-20 6:46 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 30-Oct-20 | Market Purchase | 92,040 | $25.44 | $2,341,710.00 | 63% 145.0K to 237.04K | (39%) |
06-Nov-20 6:46 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 30-Oct-20 | Market Sale | 12,969 | $26.65 | $345,559.00 | (5%) 237.04K to 224.07K | 42% |
23-Sep-20 7:09 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Conversion | 804,392 | -- | -- | 100% 0 to 804.39K | |
23-Sep-20 7:09 PM View: | Dyne Therapeutics, Inc. (DYN) | 21-Sep-20 | Purchase | 700,000 | $19.00 | $13,300,000.00 | 87% 804.39K to 1.5M |